Arizona Prescription Monitoring Program
The Arizona Prescription Monitoring Program (PMP), housed in the Arizona State Board of Pharmacy, collects data on all controlled substance prescriptions in Arizona (schedules II-V). This information assists healthcare providers in making better-informed care decisions when treating patients. The PMP also helps prevent the diversion and misuse of controlled substances at the provider, pharmacy, and patient levels. For more information about the PMP, please click here.
- New FAQ Available: Over-the-counter (“OTC”) Naloxone Approved by FDA
- OPIOID MONITORING INITIATIVE - Xylazine – An Emerging Drug Threat
- CMS - EPCS Program Guidance Regarding the Role of the Pharmacy/Pharmacist
- DATA-Waiver Program eliminated by Congress- For details, please see this announcement from the Department of Justice/DEA.
- CMS to Require Electronic Prescribing for Controlled Substances Covered Through Medicare Part D Beginning January 1, 2023
- CDC Releases UPDATED Clinical Practice Guideline for Prescribing Opioids for Pain
Providers Must Be Registered With the Prescription Monitoring Program With All Active DEA Numbers
Over-the-counter (“OTC”) Naloxone Approved by FDA
The Arizona Board of Pharmacy has drafted a FAQ addressing the recent FDA approval of OTC naloxone. Please see the new OTC Naloxone FAQ.